Reduced Dose Craniospinal Radiotherapy in Children With Medulloblastoma

Clinical Trial

Offered by: Nemours Children's
Locations: Delaware Valley and Pensacola in Florida

Trial Name

A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial.

What is the trial about?

To find out if the overall dose of radiation to the brain and spine can be reduced without decreasing rates of survival in children with medulloblastoma.

Who can participate?

> 3 and < 7 yrs of age.

What is involved?

Length of study is 14 months. Standard cancer care.